Trial Information
Inclusion Criteria:
1. Subjects who are 18 and older
2. Subjects who have at least 3 actinic keratoses on each side of the forehead
3. Subjects who signed an IRB approved informed consent
Exclusion Criteria:
1. Subjects who smoke
2. Subjects who have a photosensitizing condition such as lupus, porphyria, or similar
condition.
3. Subjects who received a diagnosis of skin cancer on the face in past year
4. Subjects who received field treatment for actinic keratoses to the face in the past
60 days
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment
Outcome Measure:
complete response rate
Outcome Time Frame:
one month after treatment
Safety Issue:
No
Authority:
United States: Institutional Review Board
Study ID:
2821 50-5
NCT ID:
NCT01812837
Start Date:
July 2012
Completion Date:
Related Keywords:
- Actinic Keratosis
- actinic keratosis
- microneedles
- photodynamic therapy
- levulan
- Aminolevulinic acid
- Keratosis
- Keratosis, Actinic
Name | Location |
UC Davis, Dermatology |
Sacramento, California 95864 |